Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: Fecal Transplantation to Eradicate Colonizing Emergent Superbugs [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating fecal microbiota transplantation to eradicate colonizing Enterobacteriaceae infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Enterobacteriaceae Infections, Fecal Microbiota Transplantation | Phase 3 | Status: RECRUITING